Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis.

ABSTRACT:

Objective

To estimate the cost-effectiveness of surgically induced weight loss relative to conventional therapy for the management of recently diagnosed type 2 diabetes in class I/II obese patients.

Research design and methods

This study builds on a within-trial cost-efficacy analysis. The analysis compares the lifetime costs and quality-adjusted life-years (QALYs) between the two intervention groups. Intervention costs were extrapolated based on observed resource utilization during the trial. The proportion of patients in each intervention group with remission of diabetes at 2 years was the same as that observed in the trial. Health care costs for patients with type 2 diabetes and outcome variables required to derive estimates of QALYs were sourced from published literature

SUBMITTER: Keating CL 

PROVIDER: S-EPMC2660478 | biostudies-literature | 2009 Apr

REPOSITORIES: biostudies-literature